Announced
Completed
AMBRX INC. / WUXI PHARMATECH (CAYMAN) INC. / SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. / HOPU INVESTMENT MANAGEMENT COMANY LTD. / CHINA EVERBRIGHT LIMITED / VERSANT VENTURES / ROCHE VENTURE FUND / CMEA VENTURES / ARAVIS VENTURES / APPOSITE CAPITAL LLP / 5AM VENTURES LLC / Public / Acquisition
Synopsis
Sale of Ambrx, a biopharmaceutical company engaged in the discovery, development, and commercialization of protein-based drugs, to a consortium of Chinese companies.
Principals
Show Details & Financials
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.